Aberrant Activation of the Hedgehog Pathway in Cutaneous Melanoma: Therapeutic Potential of Pharmacological Inhibitors
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27020762 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Federica Papaccio und 9 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, Via Elio Chian…. Hauptthemen laut MEDLINE: Melanoma, Hedgehog Proteins, Smoothened Receptor, Skin Neoplasms. Die Arbeit nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health.
Abstract (Originalsprache)
Cutaneous melanoma is a highly aggressive skin cancer prone to relapse and metastasis. Surgery is often curative when combined with early screening and prevention. However, in recurrent or advanced disease, the development of new targeted and immune therapies has demonstrated promising clinical outcomes, although the acquisition of resistance limits their effectiveness. Thus, new therapeutic approaches are needed. Emerging data indicate that the Hedgehog (Hh) pathway, which is essential for embryonic development, is aberrantly reactivated in melanoma and may represent a promising therapeutic target. Here, we demonstrate its chronic up-modulation in a panel of patient-derived cell lines and, by investigating the underlying molecular mechanisms, we excluded mutations in the principal components of the pathway. We observed reduced PTCH1 and SUFU repressors expression and GLI2 upregulation as common melanoma features. At the same time, copious SHH release, the principal PTCH1 ligand, evidenced autocrine Hh signaling activation. Consistently, a tendency of greater level of this factor resulted higher in the blood of patients compared to controls, confirming the relevance of ligand-dependent trigger in melanoma. The therapeutic potential of inhibiting the Hh pathway is highlighted by the reduced proliferation and migration observed in the presence of clinically approved pharmacological Hh antagonists. Profiling inflammatory mediators revealed significant modulation upon treatment with SMO inhibitors, possibly affecting chemotactic and immune functions. Collectively, these findings provide deeper insight into the role of the Hh pathway in melanoma and support the potential repurposing of Hh inhibitors as therapeutic agents for melanoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Cutaneous Physiopathology and Integrated Center of Metabolomics Research, San Gallicano Dermatological Institute, IRCCS, Via Elio Chianesi 53, 00144 Rome, Italy.
- Department of Plastic and Regenerative Surgery, San Gallicano Dermatological Institute, IRCCS, 00144 Rome, Italy.
- Department of Pathology, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.
- Biostatistics, Bioinformatics and Clinical Trial Center, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy.
- Genetic Research, Molecular Biology and Dermatopathology Unit, San Gallicano Dermatological Institute, 00144 Rome, Italy.
ORCID-Profile: Ramona Marrapodi, Emilia Migliano, Elisa Melucci, Stefano Scalera, Barbara Bellei
Förderung
- Italian Ministry of Health
Zitieren
APA
Papaccio, F., Kovacs, D., Marrapodi, R., Caputo, S., Migliano, E., Melucci, E., Scalera, S., Cota, C., Maugeri-Saccà, M., & Bellei, B. (2026). Aberrant Activation of the Hedgehog Pathway in Cutaneous Melanoma: Therapeutic Potential of Pharmacological Inhibitors. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27020762
Vancouver
Papaccio F, Kovacs D, Marrapodi R, Caputo S, Migliano E, Melucci E, et al. Aberrant Activation of the Hedgehog Pathway in Cutaneous Melanoma: Therapeutic Potential of Pharmacological Inhibitors. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27020762
BibTeX
@article{Papaccio2026,
author = {Papaccio, Federica and Kovacs, Daniela and Marrapodi, Ramona and Caputo, Silvia and Migliano, Emilia and Melucci, Elisa and Scalera, Stefano and Cota, Carlo and Maugeri-Saccà, Marcello and Bellei, Barbara},
title = {Aberrant Activation of the Hedgehog Pathway in Cutaneous Melanoma: Therapeutic Potential of Pharmacological Inhibitors},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27020762}
}
EUVIMED